Drug Trial Radar · NCT04423211
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Last checked: Nov 20, 2026Latest source record: Nov 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
804
Planned (sponsor's estimate)
Start
Oct 8, 2020
Primary completion
Dec 31, 2032
Study completion Dec 31, 2032
Sponsor
- Lead sponsor
- ECOG-ACRIN Cancer Research GroupResearch network
- Sponsor type
- Research network
- Collaborators
- National Cancer Institute (NCI)
- First posted
- Jun 9, 2020
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Male only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This phase III trial tests two questions by two separate comparisons of therapies. The first question is whether enhanced therapy (apalutamide in combination with abiraterone + prednisone) added to standard of care (prostate radiation therapy and short term androgen deprivation) is more effective compared to standard of care alone in patients with prostate cancer who experience biochemical recurrence (a rise in the blood level of prostate specific antigen \[PSA\] after surgical removal of the prostate cancer). A second question tests treatment in patients with biochemical recurrence who show prostate cancer spreading outside the pelvis (metastasis) by positron emission tomography (PET) imaging. In these patients, the benefit of adding metastasis-directed radiation to enhanced therapy (apalutamide in combination with abiraterone + prednisone) is tested. Diagnostic procedures, such as PET, may help doctors look for cancer that has spread to the pelvis. Androgens are hormones that may cause the growth of prostate cancer cells. Apalutamide may help fight prostate cancer by blocking the use of androgens by the tumor cells. Metastasis-directed targeted radiation therapy uses high energy rays to kill tumor cells and shrink tumors that have spread. This trial may help doctors determine if using PET results to deliver more tailored treatment (i.e., adding apalutamide, with or without targeted radiation therapy, to standard of care treatment) works better than standard of care treatment alone in patients with biochemical recurrence of prostate cancer.
Conditions
- Biochemically Recurrent Prostate Carcinoma
- Metastatic Prostate Carcinoma
- Prostate Adenocarcinoma
- Stage IVB Prostate Cancer AJCC v8
Interventions
3-Dimensional Conformal Radiation TherapyRadiation
Undergo 3D CRT
ApalutamideDrug
Given PO
Computed TomographyProcedure
Undergo PET/CT
DegarelixDrug
Given SC
External Beam Radiation TherapyRadiation
Undergo EBRT
Fluciclovine F18Other
Given IV
Goserelin AcetateDrug
Given SC
Intensity-Modulated Proton TherapyProcedure
Undergo IMPT
Intensity-Modulated Radiation TherapyRadiation
Undergo IMRT
Leuprolide AcetateDrug
Given IM
Magnetic Resonance ImagingProcedure
Undergo PET/MR
Positron Emission TomographyProcedure
Undergo PET/CT or PET/MR
Quality-of-Life AssessmentOther
Ancillary studies
Questionnaire AdministrationOther
Ancillary studies
RelugolixDrug
Given PO
Stereotactic Body Radiation TherapyRadiation
Undergo SBRT
TriptorelinDrug
Given IM
Volume Modulated Arc TherapyRadiation
Undergo VMAT
Primary outcomes
What the sponsor says the trial is designed to measure.
- Progression-free survival (PFS)Time frame: From randomization to radiographic progression by conventional imaging or positron emission tomography (PET), symptomatic disease or death, whichever occurs first, assessed up to 10 years
- PFS prolongation in patients without PET-evidence of extrapelvic metastasesTime frame: Up to 10 years
- PFS prolongation in patients with PET-evidence of extrapelvic metastasesTime frame: Up to 10 years
- Quality of life (QOL)Time frame: Up to 24 months
Locations
341 sites in 1 country. Site status is shown where the registry gives one.
Anchorage Associates in Radiation Medicine
Anchorage, Alaska · Recruiting
Alaska Breast Care and Surgery LLC
Anchorage, Alaska · Recruiting
Alaska Oncology and Hematology LLC
Anchorage, Alaska · Recruiting
Alaska Women's Cancer Care
Anchorage, Alaska · Recruiting
Anchorage Oncology Centre
Anchorage, Alaska · Suspended
Katmai Oncology Group
Anchorage, Alaska · Recruiting
Providence Alaska Medical Center
Anchorage, Alaska · Recruiting
Fairbanks Memorial Hospital
Fairbanks, Alaska · Recruiting
Cancer Center at Saint Joseph's
Phoenix, Arizona · Recruiting
Mercy Hospital Fort Smith
Fort Smith, Arkansas · Recruiting
Mission Hope Medical Oncology - Arroyo Grande
Arroyo Grande, California · Recruiting
Providence Saint Joseph Medical Center/Disney Family Cancer Center
Burbank, California · Recruiting
Mercy Cancer Center - Carmichael
Carmichael, California · Recruiting
Mercy San Juan Medical Center
Carmichael, California · Recruiting
City of Hope Corona
Corona, California · Recruiting
City of Hope Comprehensive Cancer Center
Duarte, California · Recruiting
Mercy Cancer Center - Elk Grove
Elk Grove, California · Recruiting
UC San Diego Health System - Encinitas
Encinitas, California · Recruiting
UC San Diego Moores Cancer Center
La Jolla, California · Recruiting
City of Hope Antelope Valley
Lancaster, California · Recruiting
Los Angeles General Medical Center
Los Angeles, California · Active not recruiting
USC / Norris Comprehensive Cancer Center
Los Angeles, California · Active not recruiting
UCLA / Jonsson Comprehensive Cancer Center
Los Angeles, California · Recruiting
Mercy Cancer Center
Merced, California · Suspended
VA Palo Alto Health Care System
Palo Alto, California · Active not recruiting
Mercy Cancer Center - Rocklin
Rocklin, California · Recruiting
Mercy Cancer Center - Sacramento
Sacramento, California · Recruiting
UC San Diego Medical Center - Hillcrest
San Diego, California · Recruiting
Pacific Central Coast Health Center-San Luis Obispo
San Luis Obispo, California · Recruiting
Mission Hope Medical Oncology - Santa Maria
Santa Maria, California · Recruiting
City of Hope South Pasadena
South Pasadena, California · Recruiting
Saint Joseph's Medical Center
Stockton, California · Recruiting
City of Hope Upland
Upland, California · Recruiting
BASS Medical Group - Lennon
Walnut Creek, California · Active not recruiting
Woodland Memorial Hospital
Woodland, California · Recruiting
Rocky Mountain Cancer Centers-Aurora
Aurora, Colorado · Active not recruiting
Rocky Mountain Cancer Centers-Boulder
Boulder, Colorado · Active not recruiting
Penrose-Saint Francis Healthcare
Colorado Springs, Colorado · Recruiting
Rocky Mountain Cancer Centers-Penrose
Colorado Springs, Colorado · Recruiting
Saint Francis Cancer Center
Colorado Springs, Colorado · Recruiting
Showing 40 of 341 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.